Epigral Ltd
Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals in India. Epigral’s Dahej facility is a backward and forward integrated and automated complex with a well-planned infrastructure.
In India, Epigral is the first to set up an Epichlorohydrin plant and largest capacity plant of CPVC Resin. Epigral is also a leading manufacturer of Caustic Soda, Caustic Potash, Chloromethanes, Hydrogen Peroxide, Chlorine and Hydrogen.
- Market Cap ₹ 5,193 Cr.
- Current Price ₹ 1,250
- High / Low ₹ 1,443 / 862
- Stock P/E 26.5
- Book Value ₹ 302
- Dividend Yield 0.39 %
- ROCE 17.0 %
- ROE 16.9 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.2%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chlor Alkali / Soda Ash
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
829 | 1,551 | 2,188 | 1,929 | |
567 | 1,041 | 1,499 | 1,448 | |
Operating Profit | 261 | 509 | 689 | 481 |
OPM % | 32% | 33% | 31% | 25% |
2 | 4 | 8 | 7 | |
Interest | 29 | 44 | 66 | 73 |
Depreciation | 74 | 86 | 109 | 124 |
Profit before tax | 161 | 383 | 522 | 291 |
Tax % | 37% | 34% | 32% | 33% |
101 | 253 | 353 | 196 | |
EPS in Rs | 24.48 | 60.84 | 85.03 | 47.13 |
Dividend Payout % | 0% | 0% | 6% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 33% |
TTM: | -12% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 25% |
TTM: | -45% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 34% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 30% |
Last Year: | 17% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Equity Capital | 42 | 42 | 42 | 42 |
Reserves | 432 | 684 | 1,028 | 1,213 |
Preference Capital | 211 | 211 | 110 | |
542 | 782 | 769 | 964 | |
433 | 616 | 594 | 576 | |
Total Liabilities | 1,449 | 2,124 | 2,432 | 2,794 |
1,102 | 1,068 | 1,804 | 1,767 | |
CWIP | 126 | 589 | 158 | 483 |
Investments | 0 | 0 | 21 | 21 |
221 | 467 | 450 | 524 | |
Total Assets | 1,449 | 2,124 | 2,432 | 2,794 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
229 | 284 | 626 | 398 | |
-197 | -455 | -437 | -401 | |
-32 | 195 | -200 | -8 | |
Net Cash Flow | 1 | 24 | -11 | -11 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Debtor Days | 52 | 60 | 28 | 34 |
Inventory Days | 51 | 74 | 69 | 90 |
Days Payable | 69 | 42 | 36 | 57 |
Cash Conversion Cycle | 34 | 92 | 61 | 67 |
Working Capital Days | -4 | 26 | 15 | 25 |
ROCE % | 29% | 32% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
3 May - Epigral Limited (formerly known as Meghmani Finechem Limited) informs about One-on-One VC with Investor / Analyst on 06.05.2024.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
26 Apr - Epigral Limited (formerly known as Meghmani Finechem Limited) submits transcript of Conference Call held on 22nd April, 2024 for Q4 FY 24 Results.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
24 Apr - The Company is having One-on-One VC with Axanoun Investment Management on 26.04.2024 and SBICAP Securities Limited on 29.04.2024.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 Apr - Epigral Limited (formerly known as Meghmani Finechem Limited) hereby submits Newspaper Publication of Audited Financial Results for quarter and year ended 31.03.2024
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
23 Apr - The Company is having one-on-one meeting with Investor / Analyst on 25.04.2024.
Annual reports
Concalls
-
Apr 2024TranscriptPPT
-
Apr 2024Transcript PPT REC
-
Apr 2024TranscriptNotesPPT
-
Jan 2024TranscriptPPT
-
Jan 2024Transcript PPT REC
-
Jan 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT REC
-
Sep 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Apr 2023Transcript PPT REC
-
Jan 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Apr 2022Transcript PPT
-
Apr 2022TranscriptNotesPPT
-
Jan 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
Products:[1]
MFL is the fourth largest manufacturer of Chlor-Alkali and its Derivatives company in India. The company manufactures -
a. Chloralkalis: Caustic Soda Lye and Flakes, Liquid Chlorine, Hydrogen, Caustic Potash Lye and Flakes, etc.
b. Derivatives:The company has Chlor-Alkali Derivatives in the form of Chloromethanes and Hydrogen Peroxide